Drugs that contain Ethinyl Estradiol; Segesterone Acetate

1. Drug name - ANNOVERA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10632066 THERAPEUTICSMD INC Method of providing birth control Feb, 2039

(16 years from now)

US10780047 THERAPEUTICSMD INC Method of providing birth control Feb, 2039

(16 years from now)

US10765628 THERAPEUTICSMD INC Method of providing birth control Feb, 2039

(16 years from now)

US10918649 THERAPEUTICSMD INC System for providing birth control Jun, 2039

(16 years from now)

US10925882 THERAPEUTICSMD INC System for providing birth control Jun, 2039

(16 years from now)

US10940157 THERAPEUTICSMD INC System for providing birth control Jun, 2039

(16 years from now)

Treatment: Method of contraception by inserting a vaginal system for up to 13 21/7-day (in/out) cycles, wherein efficacy requires the system cannot be out of the vagina for more than 2 cumulative hours in any such cycle without using alternative contraception; method of preventing pregnancy by inserting a vaginal system containing 103 mg of segesterone acetate and 17.4 mg ethinyl estradiol into a vagina for up to thirteen 21/7-day (in/out) cycles; Method of preventing pregnancy by inserting a vaginal system containing 103 mg of segesterone acetate and 17.4 mg ethinyl estradiol into a vagina for up to thirteen 21/7-day (in/out) cycles; method of contraception by inserting a vaginal system for up to 13 21/7-day (in/out) cycles, wherein efficacy requires the system cannot be out of the vagina for more than 2 cumulative hours in any such cycle without using alternative contraception

Dosage: RING;VAGINAL

More Information on Dosage
Strength Dosage Availability
0.013MG/24HR;0.15MG/24HR RING;VAGINAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.